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Introduction
Glutathione-S-transferase (GST) enzymes are critical players in the cellular defence against the deleterious effects of oxidative stress and electrophilic compounds, including endogenous metabolites and various anticancer agents. Increased levels of several GST family members have been associated with improved cell survival in the presence of diverse insults. The GSTP1-1 isoform has been directly related to tumor cell resistance to chemotherapy and radiation (Su et al., 2003) . Therefore, understanding the mechanisms of GST-mediated tumor cell survival and the development of inhibitors of these processes are areas of primary interest.
The various roles of GSTP1-1 in cell survival are supported by its multiple cellular functions. GSTP1-1 catalyzes the conjugation of various electrophilic compounds with the tripeptide glutathione (GSH), the adducts formed being substrates for cellular export by the multidrug transporter systems (Sibhatu et al., 2008) . GSTP1-1 has also been found to promote the glutathionylation of cellular proteins (Townsend et al., 2009 ), a process that can be considered a protective mechanism against irreversible oxidative damage and requires the catalytic activity of the enzyme. In contrast, the functions of GSTP1-1 in the sequestration of toxic compounds through covalent or noncovalent interaction, known as the "ligandin" role (Lu and Atkins, 2004) , and in the binding of signalling proteins (Adler et al., 1999; Wu et al., 2006) are independent from GSTP1-1 catalytic activity. Of particular importance is the role of GSTP1-1 in the regulation of stress signalling pathways. In non-stressed cells GSTP1-1 has been found associated with various stress activated kinases, including Traf-2 and JNK (Adler et al., 1999; Wu et al., 2006) , thus maintaining them in an inactive state. Cell stress conditions, including oxidative stress and treatment with certain GSTP1-1 inhibitors, This article has not been copyedited and formatted. The final version may differ from this version. (Adler et al., 1999; Turella et al., 2005; Wu et al., 2006) . Therefore, GSTP1-1 inhibitors and/or inducers of GSTP1-1 oligomerization are being sought as potential anticancer agents (Burg et al., 2006; Turella et al., 2005) .
Cyclopentenone prostaglandins (cyPG) are reactive lipidic mediators which arise by non-enzymatic dehydration of certain PG. cyPG display varied biological effects including anti-proliferative and anti-inflammatory actions, for which a potential pharmacological use of these compounds has been put forward (Homem de Bittencourt et al., 2007; Ianaro et al., 2003) . An important mechanism for cyPG action is the formation of covalent adducts with cellular proteins resulting in altered protein function (Cernuda-Morollón et al., 2001; Pérez-Sala et al., 2003; Sánchez-Gómez et al., 2004) .
cyPG possess an α,β-unsaturated carbonyl group in the cyclopentane ring, a structure that favours the formation of Michael adducts with thiol groups in proteins or in GSH.
Among the proteins known to be targets for modification by addition of cyPG are transcription factors, like AP-1 and NF-κB (Cernuda-Morollón et al., 2001; Pérez-Sala et al., 2003) , proteins involved in the regulation of cellular redox status, such as thioredoxin and thioredoxin reductase (Cassidy et al., 2006; Shibata et al., 2003) , and cytoskeletal proteins (Aldini et al., 2007; Stamatakis et al., 2006) , among others.
cyPG and GSTP1-1 may interact at several levels. cyPG are substrates for GSTP1-1 (Atsmon et al., 1990) , and both conjugation with glutathione and sequestration by binding to the enzyme may lead to the attenuation of cyPG effects (Paumi et al., 2004) . In turn, cyPG may inhibit GSTP1-1 activity and both covalent and non-covalent mechanisms have been invoked for this effect (Paumi et al., 2004; van Iersel et al., 1999) . We recently demonstrated the direct covalent modification of This article has not been copyedited and formatted. The final version may differ from this version.
Molecular Pharmacology Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on October 20, 2017 molpharm.aspetjournals.org Downloaded from MOL #65391 6 GSTP1-1 by the cyPG 15d-PGJ 2 , both in vitro and in intact cells (Sánchez-Gómez et al., 2007) . In addition, treatment with 15d-PGJ 2 elicited various oxidative modifications of GSTP1-1. 15d-PGJ 2 -induced GSTP1-1 modifications were associated with an irreversible inhibition of GSTP1-1 enzymatic activity and with an impairment of its protective effect on cell survival (Sánchez-Gómez et al., 2007) .
Because of the importance of GSTP1-1 oxidative modifications in catalytic activity, oligomerization and signalling functions, here we have explored the effects of various oxidative stress-inducing agents and GSTP1-1 inhibitors on GSTP1-1 oligomerization status in intact cells. The results herein described unveil a novel interaction of 15d-PGJ 2 with GSTP1-1 leading to the irreversible oligomerization of the protein. Cross-linking and inactivation of GSTP1-1 by cyPG could be exploited as a novel strategy to overcome cancer cell resistance to chemotherapy.
Materials and Methods
Reagents
Human recombinant GSTP1-1 was from Sigma or from Alpha Diagnostics Intl. Inc.
(San Antonio, TX). 15d-PGJ 2 -biotin (15d-PGJ 2 -B, N-11-oxo-prosta-5Z,9,12E,14E-tetra-1-oyl-N'-biotinoyl-1,5-diaminopentane), PGA 1 -biotin (PGA 1 -B, N-9-oxo-15S-hydroxy-prosta-10,13E-dien-1-oyl-N-biotinoyl-1,6-diaminohexane) and other prostanoids used in this study were from Cayman Chemical (Ann Arbor, MI Applied Science (Mannheim, Germany).
Cell culture and treatments
T-cell leukemia Jurkat cells, lung cancer A549 cells and primary rat mesangial cells (RMC) (Stamatakis et al., 2006) were cultured in RPMI 1460 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin. Breast carcinoma MCF-7 cells were cultured in DMEM supplemented with serum and antibiotics as above. For treatments, cells, at 500,000 cells/ml, were cultured in serumfree medium. Prostaglandins were added in dimethyl sulfoxide (DMSO) and control cells received an equivalent amount of this solvent (0.1%, final concentration).
Redox two-dimensional electrophoresis
This procedure was performed essentially as described (Cumming et al., 2004) . Jurkat cells treated with the various agents were collected in PBS containing 50 mM iodoacetamide. Cells were lysed in 20 mM Tris, pH 7.5, 0.1 mM EDTA, 0.1 mM EGTA, 0.1 mM β-mercaptoethanol, 0.5% SDS, 50 mM iodoacetamide, containing protease inhibitors (2 μg/ml each of trypsin inhibitor leupeptin and aprotinin, and 1.3 mM AEBSF). Protein concentration of cell lysates was estimated with the BCA kit.
Aliquots of cell lysates containing 10 μg of protein were analyzed by non-reducing gel electrophoresis in the first dimension. Cell lanes were then excised and subjected to a series of equilibration and washing steps consisting in: equilibration in sample buffer containing 100 mM DTT for 20 min.; three 5 min. washes with SDS running buffer; equilibration in sample buffer containing 100 mM iodoacetamide for 10 min.; three 5 min. washes with SDS running buffer. For the second dimension, lanes processed as This article has not been copyedited and formatted. The final version may differ from this version. 
Western blot
Western blot analysis was performed as previously described (Sánchez-Gómez et al., 2007) . Antibodies and dilutions used were: anti-GSTP1-1 (BD Biosciences), anti-c-Jun sc-45 (Santa Cruz Biotechnology) and anti-AU5 (Babco, Berkeley, CA) at 1:1000; anti-JNK and anti-P-JNK (Cell Signalling) at 1:500.
Plasmids and Transfections
A plasmid containing the ORF of human GSTP1-1 was obtained from Origene and subjected to mutagenesis using the Quikchange mutagenesis kit (Stratagene, La Jolla, CA) to create an EcoRI site. The ORF of GSTP1-1 was then obtained by digestion with
EcoRI and NotI and cloned into the same sites of the plasmid pECFL-KZ-AU5. The C47S, C101S and C169S mutants of GSTP1-1 were obtained by site-directed mutagenesis using the Quikchange II kit (Stratagene) and primers: 5'-GGCTCACTCAAAGCCTCCTCCCTATACGGGCAGC-3' for the C47S mutation, 5'-GGCGTGGAGGACCTCCGCTCCAAATACATCTCCC-3' for the C101S mutation and 5´-GCCCCTGGCAGCCTGGATGCGTTCCCC-3 for the C169S mutation, along with the corresponding complementary reverse oligonucleotides. The C14S mutant was obtained by the overlap extension mutagenesis technique (Pogulis et al., 1996) . Briefly, in two separate PCRs, two overlapping fragments of the GSTP1-1 sequence were amplified, using the following primers: 5'-CGAGGATCCATGCCGCCCTACACC-3'
and 5'-CAGCATGCGCAGGGCCGCGCTGCGGCC-3' for the N-terminal fragment, The overlapping fragments obtained in these PCRs were subjected to a third PCR using the flanking primers, which contain EcoRI sites, to obtain the GSTP1-1 sequence containing the C14S mutation. The GSTP1-1 C14S product was then digested with EcoRI and cloned into the same site of the pECFL-KZ-AU5 plasmid.
Cells were transfected with Lipofectamine 2000 using 1 μg of DNA per 1.5x10 6 cells. After 6 h incubation, the transfection medium was diluted with RPMI plus 10% fetal bovine serum and incubation was continued overnight. For cell treatments the medium was changed to serum free medium as described above.
Apoptosis assay
To monitor the induction of apoptosis, cells treated with the indicated agents were collected, incubated at 200,000 cells/ml in 10 mM Hepes pH 7.0, 150 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 in the presence of Annexin V-FITC (1:80 v/v) for 15 min. at 37ºC in the dark, and washed. Immediately before analysis, propidium iodide was added at 20 μg/ml final concentration. Cells were analyzed by flow cytometry on an Epics Coulter cytometer, as previously described (Pérez-Sala et al., 1998) . Western blot and detection with HRP-Streptadivin. Pull-down on Neutravidin-agarose beads was performed as previously described (Sánchez-Gómez et al., 2007) . 
Immunoprecipitation and pull-down assays
In vitro oligomerization assays
Electron microscopy
A few microliters of the Δ
12
-PGJ 2 -treated or untreated GSTP1-1 samples were applied to carbon-coated grids after glow-discharge and negatively stained with 1% uranyl acetate. Grids were observed in a JEOL 1230 electron microscope operated at 100kV
and micrographs recorded at a nominal magnification of 50,000. Micrographs were digitized in a MINOLTA scanner to a final sampling of 2.1 Å/pixel. Images of individual molecules, 697 for untreated and 1351 for Δ 12 -PGJ 2 -treated GSTP1-1, were extracted from the micrographs, centered, low-passed filtered and reference-free 2D averages obtained using methods and algorithms found in the platform EMAN (Ludtke et al., 1999) .
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Structural models
The human GSTP1-1, for which a 1.9 Å resolution crystal structure is available (PDB code 22GS), was used to obtain the molecular surface of the dimer. The distances between cysteine residues of interest were obtained using the program Swiss
PDBViewer.
Results
15d-PGJ 2 induces GSTP1-1 cross-linking while oxidative stress and enzyme inhibitors elicit reversible oligomerization
The GST oligomerization state has been reported to be modulated both by cellular redox conditions and by GST inhibitors (Adler et al., 1999; Bernardini et al., 2000; Turella et al., 2005) . Moreover, GST oligomerization has important consequences for signal transduction. Therefore we explored the induction of GSTP1-1 oligomerization by various oxidative stress-inducing agents, like H 2 O 2 and diamide ( Figure 1A ). In addition, we used 4-hydroxy-2-nonenal (HNE), a reactive aldehyde generated in micromolar levels in vivo under inflammatory or oxidative stress conditions (Esterbauer et al., 1991) and the specific GST inhibitor ethacrynic acid ( Figure 1B immunoreactive species that could be detected in non-reducing SDS-PAGE gels, including a band migrating at ~20 kDa, several oligomeric species between 50 and 75 kDa, and a smear at higher molecular weight ( Figure 2A ). These species were resolved under reducing conditions into two main bands: the GSTP1-1 monomer and a prominent 75 kDa GSTP1-1 oligomer. To confirm the irreversible nature of this oligomer we performed non-reducing followed by reducing SDS-PAGE (redox twodimensional electrophoresis), according to (Cumming et al., 2004) . In this procedure, monomers and irreversible oligomers migrate in the diagonal line of the reducing gel, whereas proteins associated by disulfide bonds dissociate into their components and migrate to the left of the diagonal. Proteins containing internal disulfide bonds, which display increased electrophoretic mobility under non-reducing conditions, migrate to the right of this line. As shown in Figure 2B , the 15d-PGJ 2 -elicited 75 kDa GSTP1-1 oligomer remains in the diagonal line of the gel showing that oligomerization is not reversible under these conditions. The 20 kDa band observed under non reducing conditions runs to the right of the diagonal line in the two-dimensional gels thus
showing that it corresponds to a GSTP1-1 monomer with an intra-molecular disulfide This article has not been copyedited and formatted. The final version may differ from this version. (Fionda et al., 2007) , 15d-PGJ 2 -induced oligomerization also occurred in the presence of 10% FCS ( Figure 2C ), indicating that micromolar concentrations of the prostanoid could be effective in a physiological environment.
15d-PGJ 2 -elicited GSTP1-1 oligomerization occurred in other cell types ( Figure   3 ). In rat mesangial cells (RMC) and A549 lung cancer cells, the characteristic 75 kDa oligomer was observed after treatment with 10 μM 15d-PGJ 2 . MCF-7 breast cancer cells do not express GSTP1-1. Therefore, to explore GSTP1-1 oligomer formation in these cells we transfected them with a GSTP1-1 expression plasmid. Treatment of MCF-7 with 10 μM 15d-PGJ 2 for 16 h did not induce GSTP1-1 oligomerization, and a short incubation with high concentration of 15d-PGJ 2 was necessary to elicit the appearance of the oligomer.
Role of GSTP1-1 cysteine residues in oligomerization induced by oxidative stress and GSTP1-1 inhibitors.
The results shown above suggested that oligomeric GSTP1-1 species induced by various treatments including H 2 O 2 , diamide, HNE or ethacrynic acid were due to the formation of disulfide bonds. Therefore, we assessed the nature of the cysteine residues involved in the formation of oligomers elicited by these agents through transient transfection of AU5-tagged GSTP1-1 wild type and cysteine to serine mutant constructs and detection of the oligomers formed by western blot with anti-AU5 antibody ( Figure   4A and B). The pattern of H 2 O 2 -induced oligomers changed remarkably by mutation of GSTP1-1 cysteine residues. In the case of C47S mutant, the formation of the 75 kDa oligomer was clearly increased ( Figure 4A ). In contrast, the C101S mutant was largely Ethacrynic acid-induced oligomerization of GSTP1-1 constructs was also fully reversible under reducing conditions, indicating that the oligomeric species are linked by disulfide-bonds.
C101 of GSTP1-1 is critical for 15d-PGJ 2 -induced oligomerization.
Since we had evidenced the irreversible nature of 15d-PGJ 2 -induced GSTP1-1 oligomerization, we studied the potential involvement of cysteine residues only under reducing conditions. As it can be observed in Figure 5A , mutation of C47 increased the proportion of oligomer formed upon treatment of Jurkat cells with 15d-PGJ 2 with respect to the wild type construct. In contrast, mutation of C101 completely abolished oligomerization. Mutation of C14 or C169 did not block GSTP1-1 oligomerization, although it tended to reduce the proportion of oligomer formed. Thus, according to these results, C101 is the only residue essential for 15d-PGJ 2 -induced GSTP1-1 crosslinking. We previously showed that a biotinylated 15d-PGJ 2 analog, (15d-PGJ 2 -B) directly bound to endogenous GSTP1-1 in cells (Sánchez-Gómez et al., 2007) . To Figure 5B ). Remarkably, a C47S mutant showed increased incorporation of 15d-PGJ 2 -B, whereas modification was totally abolished in the C101S mutant. Thus, C101 is also essential for covalent binding of 15d-PGJ 2 to GSTP1-1. Interestingly, 15d-PGJ 2 -B also elicited GSTP1-1 oligomerization in cells ( Figure 5C ). Moreover, pull-down of lysates from 15d-PGJ 2 -B-treated cells on
Neutravidin beads resulted in retention of both monomeric and oligomeric forms of GSTP1-1, indicating that both species contain bound biotinylated PG ( Figure 5D ). No GSTP1-1 was retained on avidin when lysates from cells treated with non-biotinylated 15d-PGJ 2 were used (not shown).
The dienone structure of cyPG is required for GSTP1-1 irreversible oligomerization
As we have shown above, 15d-PGJ 2 -induced GSTP1-1 oligomers are stable under strong reducing conditions (i.e., 700 mM β-mercaptoethanol or 100 mM DTT). This indicates that oligomerization is unlikely to be exclusively due to disulfide bond formation. 15d-PGJ 2 is a cyPG with dienone structure, that is, it possesses two electrophilic carbons that are able to react simultaneously with two thiol groups (Atsmon et al., 1990; Pérez-Sala et al., 2003) . To explore the potential role of this mechanism in GSTP1-1 oligomerization we employed a battery of prostanoids with single enone or dienone structure ( Figure 6A ). The cyPG Δ 12 -PGJ 2 , which possesses a dienone structure, effectively induced the formation of a 75 kDa GSTP1-1 oligomer, which was stable under reducing conditions and accounted for 50% of the with single enone structure and 9,10-dihydro-PGJ 2 , an analog of 15d-PGJ 2 , which lacks the endocyclic double bond but possesses one electrophilic carbon, did not induce the formation of oligomeric species ( Figure 6B ). Δ
12
-PGJ 2 -induced GSTP1-1 oligomers were analyzed by redox two-dimensional electrophoresis ( Figure 6C ). This analysis confirmed the stability of the 75 kDa oligomer formed, whereas other oligomeric species with lower electrophoretic mobility observed under non-reducing conditions were clearly not stable and thus their formation probably involved disulfide bonding.
Similarly, the intra-molecular disulfide bond of the fast migrating GST monomer was also reduced under these conditions.
GSTP1-1 oligomerization is associated with activation of the JNK cascade
GSTP1-1 oligomerization under oxidative stress conditions or in the presence of GSTP1-1 inhibitors has been reported to lead to the activation of the JNK cascade due to loss of its inhibitory interaction with various stress kinases, such as Traf-2 or JNK itself (Adler et al., 1999; Wu et al., 2006) . To explore whether 15d-PGJ 2 -induced GSTP1-1 oligomerization was associated with JNK activation in Jurkat cells we studied the temporal course of both phenomena ( Figure 7A ). The formation of the 75 kDa oligomer could be detected as early as 15 min after 15d-PGJ 2 addition. Importantly, the 
15d-PGJ 2 induces GSTP1-1 oligomerization in vitro.
The observation that the presence of two electrophilic carbons in cyPG is required to induce stable GST oligomerization in cells suggests that dienone cyPG may directly act as cross-linking agents by reacting with thiol groups from different GSTP1-1 monomers. To get insight into the structural aspects of 15d-PGJ 2 -induced GSTP1-1 oligomerization we explored this phenomenon in vitro. Treatment of recombinant GSTP1-1 with 15d-PGJ 2 elicited the appearance of a distinct 75 kDa oligomer of recombinant GSTP1-1 that was resistant under reducing conditions ( Figure 8A ). A detectable amount of dimer (approximately 50 kDa) was present both in control and in 15d-PGJ 2 -treated GSTP1-1 under these conditions. The presence of 15d-PGJ 2 in the 75 kDa oligomer was demonstrated by use of the biotinylated analog, which was detected by HRP-conjugated streptavidin and ECL (Fig, 8B, arrowheads) . This indicates that GSH analogues reduce 15d-PGJ 2 -GSTP1-1 interaction either by inducing conformational changes or by steric hindrance. Given the importance of C101 in GSTP1-1 oligomerization in cells, we explored the position of these residues in the GSTP1-1 molecule. In the structure of the GST dimer C101 residues from either monomer occupy a central position in the interior of a cleft formed at the subunit interface ( Figure 8C ). Distance between the two residues is estimated as 6.25 Å, which is within the range of the distance that can be cross-linked by one prostaglandin molecule ( Figure 8D ). Other dienone PG, including 15d-PGJ 2 -B and Δ 12 -PGJ 2 also induced the formation of the 75 kDa GSTP1-1 oligomer. In the view of these data we explored the ability of dibromobimane (DBB), a bifunctional agent with a cross-linking distance of approximately 6 Å, to elicit GSTP1-1 oligomerization. Interestingly, DBB, widely used to perform cysteine mapping in proteins, was able to induce several oligomeric species of GTSP1-1 in vitro, including a clear oligomer at 75 kDa ( Figure   8E , arrowhead). In contrast, the single enone cyPG PGA 1 did not induce GSTP1-1 oligomerization in vitro, as evidenced by use of its biotinylated analog (PGA 1 -B) in comparison with 15d-PGJ 2 -B ( Figure 8F ).
Analysis of GSTP1-1 oligomeric species by electron microscopy
Since Δ 12 -PGJ 2 appeared to be the most effective compound inducing GSTP1-1 oligomerization, we used Δ
12
-PGJ 2 -treated GSTP1-1 in subsequent experiments to characterize the general shape and dimensions of GSTP1-1 oligomeric forms. Samples of GSTP1-1 before and after treatment with Δ 12 -PGJ 2 were applied to a carbon support film and observed in an electron microscope after negative staining to increase the contrast. Single molecules were easily spotted in the electron microscopy fields as white This article has not been copyedited and formatted. The final version may differ from this version. (Fig 9A) . On the other hand, the molecules detected after treatment with Δ
-PGJ 2 were found to be highly heterogeneous in shape and size (not shown). Within this heterogeneity detected after treatment, most images revealed significant larger dimensions than the same protein before the treatment ( Figure 9C ). To improve the signal to noise ratio of this structural data, micrographs for each sample were taken, digitized and the images corresponding to single molecules extracted using image processing techniques. Single-molecule images were aligned and classified using reference-free methods to generate a collection of 2D averages for GSTP1-1 before ( Figure 9B ) and after treatment ( Figure 9D ).
Averaging increased the signal to noise ratio, thus permitting a better interpretation of the structural details revealed by our data ( Figure 8E ). The dimensions of the averages of GSTP1-1 were compatible with 2D projections of a dimeric GSTP1-1 as revealed by the comparison between the electron microscopy images, whose dimensions are measured based on the magnification of the microscope, and the published atomic structures ( Figure 9E , left panel). On the other hand, most averages after treatment corresponded to molecules with one dimension in the range of dimeric GSTP1-1 and the other dimension closer to double that length. This later result could be compatible with a tetramer molecule interacting in such a way that only one of the dimensions of the new oligomeric form doubles in the complex. Besides its catalytic role in the detoxification of electrophilic agents and in the modulation of protein glutahionylation, GSTP1-1 pro-survival functions depend on its oligomeric state. GSTP1-1 has been typically described to form homodimers in cells, but it can also exist in complex with other proteins involved in redox regulation (Manevich et al., 2004) or cell signalling (Adler et al., 1999; Wu et al., 2006) , thus playing a role in the modulation of stress-induced signalling cascades. Homooligomerization of GSTP1-1 under stress conditions leads to its dissociation from stress kinases such as JNK or Traf-2, thus releasing them from an inhibitory interaction and favouring the induction of apoptosis (Turella et al., 2005; Wu et al., 2006) . Consistent with these observations we found that 15d-PGJ 2 induced apoptosis in Jurkat cells in correlation with GSTP1-1 oligomerization and sustained activation of the JNK cascade.
This implies that 15d-PGJ 2 may block survival circuits elicited by GSTP1-1 which are dependent on either catalytic or non-catalytic mechanisms. In this context, failure of This article has not been copyedited and formatted. The final version may differ from this version. with lack of GSTP1-1 oligomerization in the resistant clones (Bernardini et al., 2006) , possibly due to the antioxidant defences of these cells. Interestingly, we noted that MCF-7 breast cancer cells were less susceptible to dienone cyPG-induced GSTP1-1 oligomerization and cell toxicity than Jurkat cells. A number of factors could contribute to this lack of effect. MCF-7 expressed high levels of other GST isoforms, like GSTZ.
Moreover, 15d-PGJ 2 has been reported to induce various cytoprotective effects in this cell type, including expression of HO-1 and of multidrug resistance protein (MRP1) (Song et al., 2009 ). In preliminary assays we have observed that MCF-7 cells are also more resistant than Jurkat cells to the effects of diamide, which supports the hypothesis that they possess more efficient mechanisms for cell defence against oxidants (Díez-Dacal, unpublished results). In the light of these observations, it would be interesting to explore whether monitoring GSTP1-1 oligomerization could provide an indication of drug resistance. In this line, our work outlines the conditions for the direct visualization of GSTP1-1 oligomeric species by EM, a technique that could prove valuable for obtaining structural information with limited amounts of protein.
One striking feature of the interaction of 15d-PGJ 2 with GSTP1-1 is the nature of the cysteine residue involved. Human GSTP1-1 possesses four cysteine residues, of which, C47, which displays a low pKa, is the most reactive (Jenkinson et al., 2009 ). In fact, C47 has been shown to be modified by a wide variety of compounds of diverse chemical nature. C47 has been long known to be the site of modification of GSTP1-1 by the classical inhibitor ethacrynic acid. Other α,β-unsaturated carbonyl aldehydes and ketones including acrolein, HNE and curcumin, as well as the skin sensitizer pphenylenediamine, also react with C47 (Jenkinson et al., 2009; van Iersel et al., 1997) .
Remarkably, our results show that mutation of C47 in GSTP1-1 favours modification of GST by 15d-PGJ 2 -B and 15d-PGJ 2 -induced GSTP1-1 oligomerization. This suggests that C47 may be involved in interactions that shield the modification of C101. In fact, the formation of an intra-molecular disulfide bond involving C47 and C101 under conditions of oxidative stress has been proposed (Ricci et al., 1991) . In this setting, the absence of C47, as in the C47S mutant, could favour the availability of C101 for modification by 15d-PGJ 2 . C101 appears to be less reactive, and selective modification of this residue has not been reported. Our results show that C101 is essential for 15d-PGJ 2 interaction and is also important for H 2 O 2 -induced oligomerization. This may have important implications, since a wide number of studies on the involvement of GSTP1-1 in cancer susceptibility or chemoresistance have been performed in murine models.
Since murine GSTP1-1 lacks C101 some of the results available could need to be reconsidered. Our observations also highlight the importance of using human(ized) models when studying GSTP1-1-mediated cancer chemoresistance.
An interesting question is the structural basis for the stability of the GSTP1-1 oligomer. Formation of the stable GSTP1-1 oligomer required the dienone structure of cyPG. Since dienone cyPG may react simultaneously with two nucleophilic residues (Pérez-Sala et al., 2003) this suggests that oligomer formation may involve crosslinking of GSTP1-1 through residues present in different monomers. C101 of the two monomers constituting the functional GSTP1-1 dimer are within the distance that can be cross-linked by dienone cyPG (~6Å). Indeed, the compound dibromobimane, which may cross-link cysteine residues within 3-6 Å distance (Sinz and Wang, 2001) , forms an oligomer similar to that observed after treatment with dienone cyPG. However, all the available data, the apparent molecular weight of the complex (75 kDa), the size as estimated from gel filtration analysis (70-80 kDa, unpublished data) and the size estimation from the electron microscopy images, are compatible with the formation of a This article has not been copyedited and formatted. The final version may differ from this version. been recently reported (Yamaguchi et al., 2010) , providing additional cross-linking alternatives that remain unexplored to date. Alternatively, it could be hypothesized that the oligomer observed may arise from a highly stable interaction between two GSTP1-1 dimers that could be elicited by the conformational change induced by cross-linking of C101. In addition, since cyPG induce oxidative stress in various cell types, including
Jurkat cells (Nencioni et al., 2003) , the possibility also exists that, in cells, other products derived from lipid peroxidation participate in GSTP1-1 cross-linking. These possibilities would be the subject of future studies.
Treatment with cyPG may elicit important antitumoral effects through various mechanisms (Ciucci et al., 2006) . Moreover, endogenous generation of cyPG has been invoked as a mechanism of drug action. In particular, treatment of leukaemia cells with bezafribrate and medroxyprogesterone acetate has been reported to increase synthesis and reduce metabolism of PGD 2 , leading to increased levels of 15d-PGJ 2 , recapitulating the anti-proliferative actions of exogenously added 15d-PGJ 2 (Khanim et al., 2009) .
Recently, bifunctional derivatives of GST inhibitors are been developed in order to selectively target different GST isoforms as a mechanism for antitumoral action (Maeda et al., 2006) . Since C101 is not present in most GST isoforms, future work will aim at establishing whether 15d-PGJ 2 -induced oligomerization displays isoform selectivity. In summary, the results presented in our study unveil unique features of the interaction of This article has not been copyedited and formatted. The final version may differ from this version. 
